[1] Nguyen K, Schieda N, James N, et al. Effect of phase of enhancement on texture analysis in renal masses evaluated with non-contrast-enhanced, corticomedullary, and nephrographic phase-enhanced CT images. Eur Radiol, 2021, 31(3):1676-1686. [2] 黄笳, 刘笑雷, 谭海东, 等. 健康查体人群中肝血管瘤的流行病学及临床特点分析.中华医学杂志, 2018, 98(36): 2925-2928. [3] Rodríguez Bandera AI, Sebaratnam DF, Wargon O, et al. Infantile hemangioma. Part 1: Epidemiology, pathogenesis, clinical presentation and assessment. J Am Acad Dermatol, 2021, 85(6):1379-1392. [4] Wang J, Shi A, Ding X, et al. Diagnostic value of18F-FDG PET/CT for atypical hepatic hemangioma. Jpn J Clin Oncol, 2022, 52(1):98-100. [5] 魏野, 汪施妤, 葛高华, 等. CT增强扫描与磁共振检查诊断肝血管瘤和肝细胞癌价值分析. 实用肝脏病杂志, 2024, 27(2): 279-282. [6] Cao SE, Zhang LQ, Kuang SC, et al. Multiphase convolutional dense network for the classification of focal liver lesions on dynamic contrast-enhanced computed tomography. World J Gastroenterol, 2020, 26(25):3660-3672. [7] Kim YR, Lee JE, Jung MJ. Atypical hepatic hemangioma with fluid-fluid level on ct and mri: emphasis on added value of contrast-enhanced ultrasound findings. J Belg Soc Radiol, 2022, 106(1):56. [8] Liu Z, Yi L, Chen J, et al. Comparison of the clinical and MRI features of patients with hepatic hemangioma, epithelioid hemangioendothelioma, or angiosarcoma. BMC Med Imaging, 2020, 20(1):71. [9] Hu S, Lyu X, Li W, et al. Radiomicsanalysis on noncontrast CT for distinguishing hepatic hemangioma (HH) and hepatocellular carcinoma (HCC). Contrast Media Mol Imaging, 2022, 2022:7693631. [10] 国际肝胆胰协会中国分会肝血管瘤专业委员会. 肝血管瘤诊断和治疗多学科专家共识(2019年版). 中华消化外科杂志, 2019, 18(8): 705-710. [11] Hoekstra LT, Bieze M, Erdogan D, et al. Management of giant liver hemangiomas: an update. Expert Rev Gastroenterol Hepatol, 2013, 7(3):263-268. [12] 高祥瑞, 刘红岩, 张淮, 等. 高场磁共振多b值弥散加权成像鉴别诊断肝血管瘤与肝细胞癌价值探讨. 实用肝脏病杂志, 2023, 26(1): 104-107. [13] Dane B, Shanbhogue K, Menias CO, et al. The humbling hemangioma: uncommon CT and MRI imaging features and mimickers of hepatic hemangiomas. Clin Imaging, 2021, 74:55-63. [14] Wang F, Numata K, Nihonmatsu H, et al. Added value of ultrasound-based multimodal imaging to diagnose hepatic sclerosed hemangioma before biopsy and resection. Diagnostics (Basel), 2022, 12(11):2818. [15] Yang Y, Zhou Z, Li Y. MRI-based deep learning model for differentiation of hepatic hemangioma and hepatoblastoma in early infancy. Eur J Pediatr, 2023, 182(10):4365-4368. [16] 乔斐, 郑宵阳, 赵丽. 64排螺旋CT三期增强扫描测定肝血管瘤容积价值分析. 实用肝脏病杂志, 2022, 25(3): 427-430. [17] Kacała A, Dorochowicz M, Matus I, et al. Hepatic hemangioma: Review of imaging and therapeutic strategies. Medicina (Kaunas), 2024, 60(3):449. [18] Zhao X, Liang P, Yong L, et al. Radiomics study for differentiating focal hepatic lesions based on unenhanced ct images. Front Oncol, 2022, 12:650797. [19] Li W, Li R, Zhao X, et al. Differentiation of hepatocellular carcinoma from hepatic hemangioma and focal nodular hyperplasia using computed tomographic spectral imaging. J Clin Transl Hepatol, 2021, 9(3):315-323. [20] Bhandari A, Koppen J, Wastney T, et al. A systematic review and meta-analysis of spectral CT to differentiate focal liver lesions. Clin Radiol, 2023, 78(6):430-436. [21] Shin N, Choi JA, Choi JM, et al. Sclerotic changes of cavernous hemangioma in the cirrhotic liver: long-term follow-up using dynamic contrast-enhanced computed tomography. Radiol Med, 2020, 125(12):1225-1232. [22] 孙向征, 卢微, 李若曼. 多层螺旋CT增强扫描诊断肝血管瘤与肝转移癌价值分析. 实用肝脏病杂志, 2022, 25(4):579-582. |